| Caroline Lipp, MOT, OTR/L | |
|
313 S 5th St, Odessa, DE 19730-2078 | |
| (302) 284-5810 | |
| Not Available |
| Full Name | Caroline Lipp |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 313 S 5th St, Odessa, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639672827 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | U1-0012187 (Delaware) | Primary |
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Caroline Lipp, MOT, OTR/L 313 S 5th St, Odessa, DE 19730-2078 Ph: () - | Caroline Lipp, MOT, OTR/L 313 S 5th St, Odessa, DE 19730-2078 Ph: (302) 284-5810 |
News Archive
The only available screening tests for ovarian cancer fail to catch early signs of the disease and often result in unnecessary surgery, said researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.
University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.
Phase Forward Incorporated, a leading provider of data management solutions for clinical trials and drug safety, announced that the United States Department of Justice has closed its investigation of the proposed acquisition of Phase Forward by Oracle Corporation, and that the waiting period under the Hard-Scott-Rodino Antitrust Improvements Act of 1976 regarding the Merger has been terminated.
Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for ARCALYST Injection for Subcutaneous Use for the prevention of gout flares in patients initiating uric acid-lowering therapy.
› Verified 6 days ago
Brandi Moore, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-376-4128 | |
Megan Feldmann, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-376-4128 | |
Lyndsey Fraser, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-378-5010 | |
Margaret Capelli, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Box 4010, Odessa, DE 19730 Phone: 302-376-4128 | |
Peter Thistle, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-376-4128 | |
Lacie Lynn Craft, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-388-8636 | |
Christiana Onimus, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 S 5th St, Odessa, DE 19730 Phone: 302-378-5010 |